CA-Nov16-Doc.1-rev.2
DRAFT AGENDA
67thmeeting of representatives of Members States Competent Authorities for the implementation of Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products
16-18November 2016
Starting at 9h30 on 16 November – Ending at 12h30 on 18November
Documents highlighted in yellow are not yet available on CIRCABC
1
Wednesday 16 November 2016MorningSession / 9:30 – 12:30
- Adoption of the agenda
CA-Nov16-Doc.1
- Adoption of the draft minutes of the previous CA meeting
CA-Nov16-Doc.2a (minutes 25-26 May 2016)
For adoption
CA-Nov16-Doc.2b (minutes 22-23 September 2016)
For adoption, ED session
CA-Nov16-Doc.2c (minutes 22 June 2016) / Closed session, for adoption on 18/11 morning
(9h30-12h30)
For adoption, ED session
CA-Nov16-Doc.2d (minutes 21 September 2016) / Closed session, for adoption on 18/11 morning
(9h30-12h30)
- Draft delegated acts
3.1.Draft Commission delegated regulation setting out scientific criteria for the determination of endocrine-disrupting properties pursuant to Regulation (EU) No 528/2012 / For discussion
CA-Nov16-Doc.3.1.a documents
CA-Nov16-Doc.3.1.b documents / Closed session, discussion on 18/11 morning
(9h30-12h30)
3.2.Amendment of Review programme Regulation / For information
- Biocidal products
4.1.Renewal of anticoagulant rodenticides / For information
4.1.a CMR additivity principle / For information
4.1.b Harmonised sentences for the SPC / For endorsement
CA-Nov16-Doc.4.1.b
4.1.c Concept of "tamper-resistant" bait station / For discussion and endorsement
CA-Nov16-Doc.4.1.c
CA-Nov16-Doc.4.1.d
4.2.Article 19(5) and MR procedures / For endorsement
CA-Nov16-Doc.4.2
4.3.Handling of carrier-based products / For endorsement
CA-Nov16-Doc.4.3 / * If agreed at CG-20
4.4.Linking label claims and the product authorisation / For endorsement
CA-Nov16-Doc.4.4 / * Depending on feedback from BEG
4.5.Report from Coordination Group / For information
4.6.Executive report on referrals to the Coordination Group in accordance with Article 35 of the BPR / For information
CA-Nov16-Doc.4.6
4.7.Executive report on product authorisations / For information
CA-Nov16-Doc.4.7
4.8.Executive report on applications for Union authorisation / For information
CA-Nov16-Doc.4.8.a
CA-Nov16-Doc.4.8.b
4.9.Derogations from MR according to Article 37 / For discussion
CA-Nov16-Doc.4.9
4.9.a Article 37vs Article 35/36 procedures
4.9.b Article 37(1): link between subparagraphs 1 and 2
4.10 Content of applications for authorisation of the same biocidal product
/ For discussionCA-Nov16-Doc.4.10
4.11 Request for derogations in accordance with Article 55(1)
/ For discussionCA-Nov16-Doc.4.11
CA-Nov16-Doc.4.11.a
CA-Nov16-Doc.4.11.b
Afternoon Session / 14:00 – 17:30
- Active substances
5.1.Progression of the review programme on active substances / For information
CA-Nov16-Doc.5.1
5.2.Renewal of anticoagulant rodenticides / For information
5.3.Submission of applications for the renewal of approval of active substances for the period 2016-2020 / For discussion and endorsement
CA-Nov16-Doc.5.3
5.4.Renewal of approval of active substances which are both approved and listed in Annex I to the BPR / For discussion and endorsement
CA-Nov16-Doc.5.4
5.5.Renewal of approval of creosote / For discussion
CA-Nov16-Doc.5.5
5.6.Classification and in situ generated active substances / For discussion and endorsement
CA-Nov16-Doc.5.6
CA-Nov16-Doc.5.6a
CA-Nov16-Doc.5.6b
5.7.Opinion on some declarations of interest to notify under article 15(a) of Reg.1062/2014 / For discussion and endorsement
CA-Nov16-Doc.5.7 / Closed session
5.8.Status of Croda Polymer and Article 93 / For discussion and endorsement
CA-Nov16-Doc.5.8, CA-Nov16-Doc.5.8a / Closed session
- Treated articles
Thursday17 November 2016
Morning Session / 10:30 – 12:30
- Horizontal matters
7.1.a. ECHA communications / For information
7.1.b. Dissemination ECHA / For information
CA-Nov16-Doc.7.1.b
CA-Nov16-Doc.7.1.c
CA-Nov16-Doc.7.1.d
CA-Nov16-Doc.7.1.e
7.2.Helpex / For discussion
CA-Nov16-Doc.7.2
7.3. Updated EC rules for expert groups – Rules of procedure CA biocides / For information
7.4.Maximum residue limits / For information
CA-Nov16-Doc.7.4.a
CA-Nov16-Doc.7.4.b
7.5.Obligations to product suppliers / For discussion and endorsement
CA-Nov16-Doc.7.5
7.6.Endocrine Disruptors
/ For information
7.7.Research use only (RUO) products and veterinary diagnosis / For discussion and endorsement
CA-Nov16-Doc.7.7
CA-Nov16-Doc.7.7a / Closed session
7.8.Scope of research and development provisions in the BPR / For discussion and endorsement
CA-Nov16-Doc.7.8
7.9.Review of the fee Regulation / For information
- Requests for opinions
8.1.Article 3(3) request from Sweden on whether a fuel additive is a biocidal product / For information
8.2.Viricidal use in teat dips / For information
8.3.Attractants in monitoring traps / For discussion
CA-Nov16-Doc.8.3 / Closed session
8.4.Insecticides applied on animals' skin / For discussion
CA-Nov16-Doc.8.4 / Closed session
Afternoon Session / 14:00 – 17:30
- Enforcement issues
9.1.BEG activities
9.1.a Report from 3rd BEG meeting / For information
9.1.b SANTE F biocides project / For information
- New policy developments which may affect the biocides regulatory framework
10.1.Proposal for a Regulation of the European Parliament and of the Council on medical devices, and amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 / For information
- International Matters
11.1.OECD / For information
- AOB
12.1.List of Competent Authorities and other Contact Points / For information
CA-Nov16-Doc.12.1
Next meetings (provisional):
2016
CG / CA / BEG / BPC10 - 14 October
15 November / 16-18 November / 11 November
12-16 December
2017
CG / CA / BEG / BPC / BPC's WG19 January / - / Tbd / - / I: 16-20/01
- / - / 27 February – 3 March
14 March / 15-16March / - / II: 06-10/03
- / - / 24 – 28 April
16 May / 17-18 May / - / III: 29/05-02/06
- / - / 26 – 30 June
11 July / 12 July (only SCBP) / -
19 September / 20-21 September / - / IV: 04-08/09
- / - / 02 – 06 October
21 November / 22-23 November / - / V: tbd
- / - / 11-15 December
1